AAAAAA
Results: 1-25/482
Citation: PUBLICATIONS IN THE DIRECTORY ONLINE FIRST, Supportive care in cancer, 6(6), 1998, pp. 487-487
Authors:
NEYMARK N
Citation: N. Neymark, MOVING BEYOND ACQUISITION COST REDUCTIONISM, Supportive care in cancer, 6(6), 1998, pp. 488-489
Authors:
NAGEL GA
Citation: Ga. Nagel, TUMOR-BIOLOGY-CENTER-FREIBURG,-GERMANY - FROM MOLECULAR-BIOLOGY TO SUPPORTIVE CARE, Supportive care in cancer, 6(6), 1998, pp. 492-494
Authors:
MERCADANTE S
Citation: S. Mercadante, CONTROVERSIES OVER SPINAL TREATMENT IN ADVANCED CANCER-PATIENTS, Supportive care in cancer, 6(6), 1998, pp. 495-502
Authors:
HISASHIGE A
KATAYAMA T
MIKASA H
Citation: A. Hisashige et al., HEALTH ECONOMICS OF CARE FOR PATIENTS WITH CANCER AND INTRACTABLE DISEASE IN JAPAN, Supportive care in cancer, 6(6), 1998, pp. 503-510
Authors:
OSOWSKI CL
DIX SP
LYNN M
DAVIDSON T
COHEN L
MIYAHARA T
SEXAUER MC
JOYCE R
YEAGER A
WINGARD JR
Citation: Cl. Osowski et al., AN OPEN-LABEL DOSE COMPARISON STUDY OF ONDANSETRON FOR THE PREVENTIONOF EMESIS ASSOCIATED WITH CHEMOTHERAPY PRIOR TO BONE-MARROW TRANSPLANTATION, Supportive care in cancer, 6(6), 1998, pp. 511-517
Authors:
BREDART A
RAZAVI D
DELVAUX N
GOODMAN V
FARVACQUES C
VANHEER C
Citation: A. Bredart et al., A COMPREHENSIVE ASSESSMENT OF SATISFACTION WITH CARE FOR CANCER-PATIENTS, Supportive care in cancer, 6(6), 1998, pp. 518-523
Authors:
CASTAGNOLA E
PAOLA D
GIACCHINO R
ROSSI R
VISCOLI C
Citation: E. Castagnola et al., ECONOMIC-ASPECTS OF EMPIRIC ANTIBIOTIC-THERAPY FOR FEBRILE NEUTROPENIA IN CHILDREN WITH CANCER, Supportive care in cancer, 6(6), 1998, pp. 524-528
Authors:
BRUERA E
FORNELLS H
PEREZ E
TATTANGELO M
NEUMANN CM
Citation: E. Bruera et al., BUS ROUNDS FOR MEDICAL CONGRESSES ON PALLIATIVE CARE, Supportive care in cancer, 6(6), 1998, pp. 529-532
Authors:
PRICE TJ
PATTERSON WK
OLVER IN
Citation: Tj. Price et al., RIFAMPICIN AS TREATMENT FOR PRURITUS IN MALIGNANT CHOLESTASIS, Supportive care in cancer, 6(6), 1998, pp. 533-535
Authors:
TANAKA K
AKECHI T
YAMAZAKI M
HAYASHI R
NISHIWAKI Y
UCHITOMI Y
Citation: K. Tanaka et al., NEUROLEPTIC MALIGNANT SYNDROME DURING HALOPERIDOL TREATMENT IN A CANCER-PATIENT - A CASE-REPORT, Supportive care in cancer, 6(6), 1998, pp. 536-538
Authors:
PHILIP J
SMITH WB
CRAFT P
LICKISS N
Citation: J. Philip et al., CONCURRENT VALIDITY OF THE MODIFIED EDMONTON SYMPTOM ASSESSMENT SYSTEM WITH THE ROTTERDAM SYMPTOM CHECKLIST AND THE BRIEF PAIN INVENTORY, Supportive care in cancer, 6(6), 1998, pp. 539-541
METHODOLOGY FOR CLINICAL-TRIALS IN CANCER-PATIENTS WITH FEBRILE NEUTROPENIA - DO WE HAVE A CONSENSUS
Authors:
FELD R
Citation: R. Feld, METHODOLOGY FOR CLINICAL-TRIALS IN CANCER-PATIENTS WITH FEBRILE NEUTROPENIA - DO WE HAVE A CONSENSUS, Supportive care in cancer, 6(5), 1998, pp. 423-424
Authors:
SBANOTTO A
BURNHILL R
Citation: A. Sbanotto et R. Burnhill, PALLIATIVE CARE IN ITALY - THE CURRENT SITUATION, Supportive care in cancer, 6(5), 1998, pp. 426-429
Authors:
KOSHY RC
RHODES D
DEVI S
GROSSMAN SA
Citation: Rc. Koshy et al., CANCER PAIN MANAGEMENT IN DEVELOPING-COUNTRIES - A MOSAIC OF COMPLEX ISSUES RESULTING IN INADEQUATE ANALGESIA, Supportive care in cancer, 6(5), 1998, pp. 430-437
Authors:
PAESMANS M
Citation: M. Paesmans, STATISTICAL CONSIDERATIONS IN CLINICAL-TRIALS TESTING EMPIRIC ANTIBIOTIC REGIMENS IN PATIENTS WITH FEBRILE NEUTROPENIA, Supportive care in cancer, 6(5), 1998, pp. 438-443
Authors:
FELD R
Citation: R. Feld, CRITERIA FOR RESPONSE IN PATIENTS IN CLINICAL-TRIALS OF EMPIRIC ANTIBIOTIC REGIMENS FOR FEBRILE NEUTROPENIA - IS THERE AGREEMENT, Supportive care in cancer, 6(5), 1998, pp. 444-448
Authors:
SCHIMPFF SC
Citation: Sc. Schimpff, EMPIRIC THERAPY FOR THE FEBRILE NEUTROPENIC PATIENT - DESIGN BIAS, Supportive care in cancer, 6(5), 1998, pp. 449-456
Authors:
ELTING LS
Citation: Ls. Elting, STRATIFICATION IN CLINICAL-TRIALS OF FEBRILE NEUTROPENIA, Supportive care in cancer, 6(5), 1998, pp. 457-461
Authors:
JUNGI WF
BERNHARD J
HURNY C
SCHMITZ SFH
HANSELMANN S
GUSSET H
PESTALOZZI D
GOLDHIRSCH A
Citation: Wf. Jungi et al., EFFECT OF CARBOPLATIN ON RESPONSE AND PALLIATION IN HORMONE-REFRACTORY PROSTATE-CANCER, Supportive care in cancer, 6(5), 1998, pp. 462-468
Authors:
HAMARSTROM V
PAUKSEN K
SVENSSON H
OBERG G
PAUL C
LJUNGMAN P
Citation: V. Hamarstrom et al., TETANUS IMMUNITY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, Supportive care in cancer, 6(5), 1998, pp. 469-472
Authors:
WHITMORE JB
KRIS MG
HESKETH PJ
GROTE TH
DUBOIS DM
CRAMER MB
HAHNE WF
Citation: Jb. Whitmore et al., RATIONALE FOR THE USE OF A SINGLE FIXED INTRAVENOUS DOLASETRON DOSE FOR THE PREVENTION OF CISPLATIN-INDUCED NAUSEA AND VOMITING - POOLED ANALYSIS OF 14 CLINICAL-TRIALS, Supportive care in cancer, 6(5), 1998, pp. 473-478
Authors:
VASSILOPOULOS PP
FILOPOULOS E
KELESSIS N
GONTIKAKIS M
PLATANIOTIS G
Citation: Pp. Vassilopoulos et al., COMPETENT GASTROSTOMY FOR PATIENTS WITH HEAD AND NECK-CANCER, Supportive care in cancer, 6(5), 1998, pp. 479-481
Authors:
MERCADANTE S
Citation: S. Mercadante, OPIOID RESPONSIVENESS IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER, Supportive care in cancer, 6(5), 1998, pp. 482-485
Authors:
BRUERA E
Citation: E. Bruera, WHEN DRYNESS RULES, Supportive care in cancer, 6(4), 1998, pp. 331-331